Ocular Therapeutix Inc. (OCUL)
NASDAQ: OCUL
· Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT
Ocular Therapeutix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 56.6M | 59.58M | 63.66M | 61.38M | 60.91M | 59.65M | 58.31M | 57.59M | 54.6M | 51.68M | 51.49M | 49.73M | 49.91M | 49.37M | 43.52M | 38.56M | 32.28M | 22.14M |
Cost of Revenue | 6M | 5.56M | 5.63M | 5.78M | 5.6M | 5.39M | 5.28M | 4.91M | 4.6M | 4.46M | 4.54M | 4.63M | 4.87M | 4.81M | 4.41M | 3.98M | 3.12M | 2.16M |
Gross Profit | 50.6M | 54.02M | 58.04M | 55.6M | 55.31M | 54.26M | 53.03M | 52.68M | 50M | 47.23M | 46.95M | 45.09M | 45.04M | 44.55M | 39.12M | 34.58M | 29.17M | 19.98M |
Operating Income | -228.13M | -204.08M | -171.78M | -141.25M | -114.47M | -91.45M | -82.38M | -81.69M | -84.02M | -83.37M | -78.65M | -77.34M | -75.33M | -75.64M | -78.03M | -74.33M | -68.81M | -66.46M |
Interest Income | 17.61M | 20.19M | 20.28M | 17.07M | 12.63M | 7.34M | 3.98M | 2.95M | 2.02M | 1.34M | 799K | 382K | 104K | 39K | 33K | 33K | 32K | 41K |
Pretax Income | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M | -67.06M | -90.73M | -88.81M | -71.04M | -59.35M | -32.5M | -22.22M | -6.55M | -88.31M | -102.92M | -131M |
Net Income | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -86.82M | -69.32M | -95.64M | -92.57M | -63.42M | -57.23M | -27.74M | -18.61M | -8.23M | -88.31M | -102.92M | -131M |
Selling & General & Admin | 106.82M | 108.41M | 102.24M | 94.07M | 89.16M | 78.86M | 74.49M | 76.1M | 76.92M | 75.49M | 72.14M | 69.93M | 68.87M | 67.94M | 67.07M | 63.79M | 58.62M | 52.92M |
Research & Development | 171.98M | 149.76M | 127.64M | 102.84M | 80.81M | 67.04M | 61.05M | 58.4M | 57.1M | 55.11M | 53.46M | 52.5M | 51.5M | 52.26M | 50.08M | 45.13M | 39.36M | 33.52M |
Other Expenses | n/a | n/a | n/a | 1K | 1K | 1K | n/a | -1K | n/a | n/a | -1K | -1K | -2K | -1K | 1K | 1K | 1K | n/a |
Operating Expenses | 278.8M | 258.17M | 229.88M | 196.91M | 169.97M | 145.9M | 135.54M | 134.5M | 134.02M | 130.6M | 125.61M | 122.43M | 120.37M | 120.19M | 117.15M | 108.92M | 97.98M | 86.44M |
Interest Expense | 6.36M | 6.54M | 13.58M | 14.62M | 14.83M | 13.62M | 11.34M | 9.03M | 7.4M | 7.11M | 7.02M | 6.86M | 6.72M | 6.68M | 6.67M | 6.72M | 6.77M | 6.81M |
Selling & Marketing Expenses | 49.29M | 45.55M | 41.59M | 4.27M | 3.02M | 4.17M | 4.83M | 41.84M | 42.71M | 41.69M | 39.92M | 38.52M | 37.91M | 36.17M | 35.19M | 32.86M | 29.81M | 27.57M |
Cost & Expenses | 284.8M | 263.73M | 235.5M | 202.7M | 175.57M | 151.29M | 140.82M | 139.41M | 138.63M | 135.05M | 130.15M | 127.07M | 125.24M | 125.01M | 121.56M | 112.89M | 101.09M | 88.6M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | 6.08M | 2.26M | 4.91M | 3.75M | -7.62M | -2.12M | -4.76M | -3.61M | 1.68M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 84.43M | 79.37M | 78.05M | 77.39M | 77.01M | 76.98M | 82.53M | 82.51M | 76.62M | 76.55M | 76.32M | 76.07M |
Shares Outstanding (Diluted) | 172.59M | 169.4M | 168.02M | 166.99M | 165.82M | 132.02M | 84.43M | 85.14M | 78.05M | 77.39M | 77.01M | 76.98M | 82.53M | 82.51M | 82.39M | 85.45M | 82.09M | 87.25M |
EPS (Basic) | -1.28 | -1.15 | -1.26 | -1.32 | -1.11 | -1.11 | -1.09 | -0.89 | -1.23 | -1.18 | -0.8 | -0.72 | -0.34 | -0.24 | -0.11 | -1.25 | -1.47 | -2 |
EPS (Diluted) | -1.28 | -1.15 | -1.26 | -1.32 | -1.11 | -1.11 | -1.09 | -0.89 | -1.23 | -1.18 | -0.8 | -0.71 | -0.59 | -0.48 | -0.64 | -1.78 | -1.72 | -2.26 |
EBITDA | -204.33M | -180.18M | -176.14M | -155.92M | -141.94M | -120.35M | -88.54M | -77.63M | -81.19M | -79.67M | -61.91M | -50.3M | -47.35M | -37.05M | -46.33M | -127.95M | -118.58M | -146.53M |
EBIT | -210.39M | -186.17M | -179.93M | -159.72M | -123.54M | -101.65M | -69.4M | -58.03M | -83.33M | -81.71M | -64.02M | -52.49M | -25.78M | -15.54M | 119K | -81.6M | -96.14M | -124.19M |
Depreciation & Amortization | 6.06M | 5.99M | 3.79M | 3.79M | 3.72M | 3.42M | 2.98M | 2.52M | 2.13M | 2.04M | 2.11M | 2.19M | 2.27M | 2.33M | 2.42M | 2.52M | 2.59M | 2.69M |